|
|
||||||||
J Thorac Cardiovasc Surg 2008;135:453-454
© 2008 The American Association for Thoracic Surgery
Brief Communication |
Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton and Harefield Hospital, National Heart and Lung Institute, Imperial College for Science, Technology and Medicine, London, United Kingdom
Received for publication August 17, 2007; revisions received October 5, 2007; accepted for publication October 15, 2007. * Address for reprints: Asghar Khaghani, FRCS, Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton and Harefield Hospital NHS Trust, Hill End Rd, Harefield, Middlesex, London UB9 6JH, United Kingdom. (Email: S.Haj-Yahia{at}imperial.ac.uk).
Successful myocardial recovery in patients with end-stage heart failure after left ventricular assist device (LVAD) support combined with pharmacologic therapy is frequently encountered in our institution.1
Minor surgical trauma in explanting ventricular assist devices (VADs) from recovered patients plays an important role in a successful bridge-to-recovery procedure.2,3
We report a minimally invasive technique for explanting the HeartMate II LVAD (ThermoCardiosystems, Inc, Woburn, Mass).
The technique consists of a small (approximately 5 cm) left anterolateral thoracotomy through the fifth intercostal space, followed by a small right anterior parasternal thoracotomy (approximately 4 cm) through the second intercostal space and a small superior epigastric incision (approximately 5 cm) dissecting and exposing the apex, the outflow joints, and the body of the device, respectively (
Figure 1). Cardiopulmonary bypass (CPB) is established through arterial cannulation in the LVAD outflow line and femoral vein cannulation for venous return (Figure 1, B). The VAD is switched off, the outflow line is clamped below the CPB arterial cannulation site, and the heart is fibrillated after beginning CPB.
|
|
Removing LVADs after myocardial recovery can be very difficult and challenging because of dense mediastinal adhesions and the risk of surgical trauma during the dissection, which can be very damaging to the recovered heart. Additionally, a full sternotomy and mobilization of the heart can cause excessive bleeding, requiring more blood and blood products, which might affect the pulmonary vascular resistance and subsequently might be detrimental to the right ventricular function.
For that reason, we think that the avoidance of median sternotomy and mobilization of the heart by limiting the surgical approach contributes to the success of the bridge to recovery and has improved our final results.1
It also can facilitate the patient's postoperative recovery and mobilization.
The HeartMate II LVAD can be explanted by using a minimally invasive surgical technique. This procedure might play an important role in explant success, maintaining good ventricular function and reducing complications in recovered patients with LVADs.
Acknowledgments
We thank the Harefield VAD team for their help in data collection and their dedicated care to all patients receiving VADs.
References
This article has been cited by other articles:
![]() |
E. J. Birks, R. S. George, M. Hedger, T. Bahrami, P. Wilton, C. T. Bowles, C. Webb, R. Bougard, M. Amrani, M. H. Yacoub, et al. Reversal of Severe Heart Failure With a Continuous-Flow Left Ventricular Assist Device and Pharmacological Therapy: A Prospective Study Circulation, February 1, 2011; 123(4): 381 - 390. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |